Seoul, South Korea

Byeong Min Jo


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Byeong Min Jo: Innovator in Radiopharmaceuticals

Introduction

Byeong Min Jo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative methods for preparing fluorine-18-labeled compounds. His work is crucial for advancements in medical imaging and treatment.

Latest Patents

Byeong Min Jo holds a patent for a method titled "Method for preparing fluorine-18-labeled fluoromethyl-substituted radiopharmaceuticals using selective azide substitution reaction and precursor scavenging." This patent outlines a comprehensive process that includes obtaining fluoride from a cyclotron, separating it, and conducting a series of reactions to produce a fluorine-18-labeled radiopharmaceutical. The method emphasizes the use of selective azide substitution and precursor scavenging, showcasing his innovative approach to enhancing the efficiency of radiopharmaceutical preparation. He has 1 patent to his name.

Career Highlights

Byeong Min Jo is currently associated with Bik Therapeutics Inc., where he continues to push the boundaries of research in radiopharmaceuticals. His work at the company reflects his commitment to developing advanced medical solutions that can improve patient outcomes.

Collaborations

He collaborates with Ying Qing Lu, contributing to the innovative research environment at Bik Therapeutics Inc. Their partnership exemplifies the collaborative spirit essential for breakthroughs in the field.

Conclusion

Byeong Min Jo's contributions to the field of radiopharmaceuticals through his innovative methods and collaborations highlight his role as a key inventor in this vital area of medical research. His work continues to pave the way for advancements that can significantly impact healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…